Name: Global Medical Device Registration Timeline Database
Creator: Pure Global

Question 1

What's the difference between Official and Realistic timelines?

Accepted Answer

Official timelines are targets set by regulatory agencies (e.g., FDA's 90-day goal for 510(k)), assuming perfect submissions. Realistic timelines reflect actual industry experience, including preparation time, questions from regulators, and typical delays based on industry surveys.

Question 2

How can Pure Global achieve faster timelines?

Accepted Answer

Pure Global's accelerated estimates are based on: expert regulatory strategy from day one, complete high-quality submissions that minimize questions, leveraging MDSAP and prior approvals strategically, pre-submission consultations with regulators, and parallel processing across markets.

Question 3

Which prior approvals help the most?

Accepted Answer

The impact varies by target market. Singapore with FDA + EU approval enables instant IBR registration (<1 hour). Brazil with FDA/TGA/Health Canada is 30% faster via IN 290/2024. Mexico with FDA is 50-70% faster via equivalency pathway. India with GHTF countries saves 6-12 months. Australia with EU CE Mark is 30-50% faster for Class III devices.

Question 4

Should I get MDSAP certification?

Accepted Answer

Yes, if you're targeting multiple markets. MDSAP is mandatory for Canada Class II-IV devices, highly beneficial for Brazil (extends B-GMP to 4 years), and accepted by Japan, Australia, and FDA. One MDSAP audit can replace 5 separate regulatory audits, saving significant time and cost.

Question 5

Which market is fastest to enter?

Accepted Answer

It depends on your device class and existing approvals. For Class I devices: Australia TGA (~1 week), Singapore (~1 week), Canada (~2-3 months). With FDA + EU approval: Singapore IBR (<1 hour). With FDA approval: Mexico equivalency (2-5 months). With EU CE Mark: UK (immediate during transition), Australia (3-5 weeks).

Question 6

How long does FDA 510(k) clearance take?

Accepted Answer

FDA's official goal is 90 FDA days under MDUFA V. However, realistic timelines are 6-12 months including preparation. With Pure Global expert support, expect 8-10 months. The actual review time averages 160-176 calendar days.

Question 7

How long does EU MDR CE marking take?

Accepted Answer

EU MDR timelines vary significantly by class. Class I self-certification: 4-6 months with Pure Global. Class IIa: 10-14 months. Class IIb: 12-18 months. Class III: 18-30 months. Notified Body capacity constraints have doubled review times from historical norms.

Question 8

How long does China NMPA registration take?

Accepted Answer

China NMPA registration is among the longest globally. Class I devices require 5-10 days for filing. Class II devices take 12-24 months realistically. Class III devices require 24-48 months including mandatory clinical trials in China for most device types. In-country testing at NMPA-designated labs is required.

Question 9

Do I need clinical trials for medical device registration?

Accepted Answer

Clinical trial requirements vary by country and device class. FDA PMA devices almost always require US clinical trials. EU MDR Class III often requires clinical investigations. China NMPA requires in-country clinical trials for most Class II/III devices. Brazil, Japan, and Australia generally accept foreign clinical data from recognized regulatory authorities.

Question 10

How long is medical device registration valid?

Accepted Answer

Registration validity varies significantly: USA requires annual establishment registration. EU CE certificates are valid for 5 years. China NMPA registration is valid for 5 years. Brazil ANVISA registration is valid for 5 years (10 years with MDSAP). Japan PMDA Shonin approval has no expiration but requires periodic renewals. Australia TGA registration is valid for 5 years.

Question 11

What is the best market entry strategy for medical devices?

Accepted Answer

The optimal strategy depends on your target markets. For global expansion, start with FDA 510(k) and EU MDR in parallel—these unlock expedited pathways in 15+ countries. Add MDSAP certification to cover Canada, Brazil, Japan, and Australia efficiently. Singapore and Mexico offer fast secondary market entry with FDA approval. Avoid starting with China unless it is your primary market due to lengthy timelines.

Question 12

What is a local authorized representative and when do I need one?

Accepted Answer

Most countries require foreign manufacturers to appoint a local authorized representative. In the USA, this is called a US Agent. In the EU, an EC REP or European Authorized Representative. Brazil requires a BRH (Brazil Registration Holder). Japan requires a DMAH (Designated Marketing Authorization Holder). These representatives handle regulatory correspondence, maintain technical files, and ensure compliance with local requirements.

Country	Class	Official	Realistic	Speedup	With Prior Approval From
United States	510(k)(Premarket Notification)	3 months	6-12 months	6-8 months	Prior 510(k) as predicate, Pre-Sub meeting
	De Novo(De Novo Classification)	5 months	8-15 months	-	-
	PMA(Premarket Approval)	6 months	4-8 years	4-6 years	Breakthrough Device Designation
European Union	Class I(Self-certification)	3-6 months	6-9 months	-	-
	Class IIa(Notified Body certification)	8-12 months	1.1-1.5 years	-	-
	Class IIb(Notified Body certification)	1-1.5 years	1.3-2 years	-	-
	Class III(Full Notified Body review)	1.5-2 years	2-3 years	-	-
China	Class I(Filing/Recordation)	1 week	2-4 months	-	-
	Class II(Provincial Registration)	4 months	1-1.5 years	-	-
	Class III(NMPA Registration)	5-6 months	2-3 years	1.2-1.7 years	Priority review for innovative devices, Hainan pilot
Japan	Class I(Notification (Todokede))	1 month	1 month	-	-
	Class II(Certification (Ninsho) or Approval (Shonin))	3-12 months	5-17 months	4-7 months	MDSAP certification, Foreign clinical data (if GCP compliant)
	Class III(Certification (Ninsho) or Approval (Shonin))	3-12 months	5-17 months	4-7 months	MDSAP certification, Foreign clinical data (if GCP compliant)
	Class IV(Approval (Shonin))	1-1.2 years	1.5-2 years	1-2 years	SAKIGAKE designation, MDSAP
Brazil	Class I(Notification)	1 month	1-1.5 months	-	-
	Class II(Notification)	1 month	1-1.5 months	-	-
	Class III(Registration)	8-12 months	1-11 months	8-12 months	FDA 510(k)/PMA (via IN 290/2024), MDSAP for B-GMP
	Class IV(Registration)	8-12 months	1-11 months	10-14 months	FDA 510(k)/PMA (via IN 290/2024), MDSAP for B-GMP
Canada	Class I(MDEL Only (no device license))	4 months	2-3 months	-	-
	Class II(Device License)	2 weeks	1-1.5 months	-	-
	Class III(Device License with clinical data)	2.5 months	3-4 months	-	-
	Class IV(Device License)	3 months	4-5 months	-	-
Australia	Class I(Notification)	0-1 weeks	0.5-1 months	-	-
	Class IIa(Conformity Assessment)	1 month	1-1.5 months	0.8-1 months	EU CE Mark, FDA 510(k), MDSAP
	Class IIb(Enhanced Assessment)	1.5 months	1.5-2 months	1-1.5 months	EU CE Mark, FDA 510(k), MDSAP
	Class III(Full Assessment)	5-7.5 months	6-9 months	3-5 months	EU CE Mark (30-50% faster), FDA 510(k), MDSAP
United Kingdom	Class I(Self-declaration or CE Mark)	0.5-1 months	0.5-1 months	2-3 weeks	EU CE Mark (accepted until 2028+)
	Class IIa(UKCA (UK Approved Body) or CE Mark)	3-6 months	3-6 months	0.5-1 months	EU CE Mark (accepted until Jun 2028)
	Class IIb(UKCA (UK Approved Body) or CE Mark)	4-8 months	4-8 months	0.5-1 months	EU CE Mark (accepted until Jun 2028 or Dec 2027 for implantables)
	Class III(UKCA (UK Approved Body) or CE Mark)	6-12 months	6-12 months	0.5-1 months	EU CE Mark (accepted until Dec 2027 for Class III)
South Korea	Class I(Self-declaration)	1-2 weeks	1-2 weeks	-	-
	Class II(MFDS Review)	2-4 months	3-6 months	2-4 months	MDSAP for K-GMP
	Class III(MFDS Review with clinical data)	4-8 months	6-12 months	-	-
	Class IV(MFDS Review with extensive clinical)	8-12 months	10-15 months	-	-
India	Class A(Registration)	3-6 months	6-9 months	3-5 months	GHTF country approval (FDA, EU, Japan, Australia, UK)
	Class B(Registration)	4-8 months	8-12 months	4-7 months	GHTF country approval
	Class C(Registration with clinical data)	6-12 months	1-1.5 years	6-9 months	GHTF country approval with predicate
	Class D(Registration with extensive clinical)	8-15 months	1.3-2 years	8-12 months	GHTF country approval
Mexico	Class I(Libre de Venta (LR) or Registration)	0.5-1 months	3 months	-	-
	Class II(Registration or Equivalency)	1-1.5 months	1.3-2.6 years	8-16 months	FDA 510(k), Health Canada, Japan PMDA, IMDRF Committee Members, MDSAP
	Class III(Registration or Equivalency)	1.5-2 months	1.3-2.6 years	8-16 months	FDA 510(k)/PMA, Health Canada, Japan PMDA, IMDRF Committee Members, MDSAP
Saudi Arabia	Class A(MDNR Listing)	1 week	1-2 weeks	-	-
	Class B(MDMA Registration)	1-2 months	1.5-3 months	-	-
	Class C(MDMA Registration)	2-4 months	3-5 months	-	-
	Class D(MDMA Registration)	3-5 months	4-6 months	-	-
Singapore	Class A(Notification)	Immediate	Immediate	-	-
	Class B(IBR/Expedited/Full Route)	5-8 months	3-9 months	Immediate	TGA, Health Canada, MHLW, FDA, EU NB
	Class C(IBR/Expedited/Full Route)	6-10.5 months	6-12 months	Immediate	TGA, Health Canada, MHLW, FDA, EU NB
	Class D(IBR/Expedited/Full Route)	8-15 months	9-18 months	6-12 months	TGA, Health Canada, MHLW, FDA, EU NB
Taiwan	Class I(Registration)	1-3 months	3-7 months	-	-
	Class II(Registration)	6-10 months	9-14 months	6-9 months	FDA 510(k), EU CE Mark, Japan PMDA
	Class III(Registration with clinical data)	8-12 months	1-1.5 years	8-11 months	FDA 510(k)/PMA, EU CE Mark, Japan PMDA
Argentina	Class I(Registration)	2-4 months	4-6 months	-	-
	Class II(Registration)	4-8 months	6-12 months	4-7 months	FDA 510(k), EU CE Mark
	Class III(Registration with clinical data)	8-12 months	1-1.5 years	8-12 months	FDA 510(k)/PMA, EU CE Mark
	Class IV(Full Registration)	1-1.5 years	1.5-2 years	1-1.3 years	FDA PMA, EU CE Mark Class III
Colombia	Class I(Notification (NSO))	2 days	1-2 months	-	-
	Class IIa(Registration (NSO))	2 days	1-2 months	2-3 months	EU CE Mark, Japan, TGA, Health Canada, FDA, MHRA, HSA
	Class IIb(Registration (RSO))	3 months	6-12 months	4-6 months	EU CE Mark, Japan, TGA, Health Canada, FDA, MHRA, HSA
	Class III(Full Registration (RSO))	3 months	9-18 months	6-10 months	EU CE Mark, Japan, TGA, Health Canada, FDA, MHRA, HSA
Peru	Class I(Notification)	1-2 months	2-4 months	-	-
	Class II(Registration)	3-6 months	4-8 months	3-5 months	FDA 510(k), EU CE Mark, ANVISA
	Class III(Registration)	4-8 months	6-12 months	4-7 months	FDA 510(k)/PMA, EU CE Mark, ANVISA
	Class IV(Full Registration)	6-10 months	8-15 months	5-8 months	FDA PMA, EU CE Mark Class III
Switzerland	Class I(Self-certification)	2-4 months	3-5 months	1-2 months	EU CE Mark (full recognition until 2028)
	Class IIa(Conformity Assessment)	4-8 months	6-10 months	0.5-2 months	EU CE Mark (immediate access)
	Class IIb(Enhanced Conformity Assessment)	6-12 months	8-14 months	0.5-2 months	EU CE Mark (immediate access)
	Class III(Full Assessment)	10-18 months	1-2 years	0.5-2 months	EU CE Mark (immediate access)
Israel	Class A(Registration)	1-2 months	2-4 months	1-2 months	FDA, EU CE Mark
	Class B(Registration)	2-4 months	3-6 months	2-3 months	FDA 510(k), EU CE Mark
	Class C(Registration with clinical data)	4-8 months	6-12 months	3-6 months	FDA 510(k), EU CE Mark
	Class D(Full Registration)	6-12 months	9-18 months	5-10 months	FDA PMA, EU CE Mark Class III
United Arab Emirates	Class A(Registration)	1-2 months	2-3 months	1-2 months	FDA, EU CE Mark, Health Canada, Australia TGA
	Class B(Registration)	2-4 months	3-6 months	2-3 months	FDA 510(k), EU CE Mark, Health Canada
	Class C(Registration)	3-6 months	4-8 months	3-5 months	FDA 510(k), EU CE Mark, Health Canada, Australia TGA
	Class D(Full Registration)	4-8 months	6-12 months	4-7 months	FDA PMA, EU CE Mark Class III
Egypt	Class A(Notification)	1-3 months	2-4 months	-	-
	Class B(Registration)	3-6 months	4-9 months	3-5 months	FDA, EU CE Mark
	Class C(Registration)	4-8 months	6-12 months	4-7 months	FDA 510(k), EU CE Mark
	Class D(Full Registration)	6-12 months	9-18 months	6-10 months	FDA PMA, EU CE Mark Class III
Indonesia	Class A(Notification)	1-2 months	2-4 months	-	-
	Class B(Registration)	4-5 months	4-6 months	-	ASEAN MRA countries, FDA, EU CE Mark
	Class C(Full Registration)	4-5 months	4-6 months	-	ASEAN MRA countries, FDA, EU CE Mark
	Class D(Full Registration)	5 months	5-7 months	-	ASEAN MRA countries, FDA, EU CE Mark
Malaysia	Class A(Registration)	1-3 months	1-3 months	-	-
	Class B(Registration)	3-6 months	3-6 months	3-6 months	EU CE Mark, MHLW, TGA, Health Canada, FDA, MHRA, HSA, TFDA
	Class C(Registration)	3-6 months	3-6 months	3-6 months	EU CE Mark, MHLW, TGA, Health Canada, FDA, MHRA, HSA, TFDA
	Class D(Full Registration)	3-6 months	3-6 months	3-6 months	EU CE Mark, MHLW, TGA, Health Canada, FDA, MHRA, HSA, TFDA
Thailand	Class 1(Notification)	0-1 months	0-2 months	-	-
	Class 2(Registration)	9-9.5 months	4-5 months	-	FDA, EU CE Mark, Japan, TGA, Health Canada, WHO (for IVD)
	Class 3(Registration)	9-9.5 months	4-5 months	-	FDA, EU CE Mark, Japan, TGA, Health Canada, WHO (for IVD)
	Class 4(Full Registration)	11-12.5 months	4-5 months	-	FDA, EU CE Mark, Japan, TGA, Health Canada, WHO (for IVD)
Vietnam	Class 1(Notification)	1-2 weeks	1-2 weeks	-	-
	Class 2(Notification)	1-2 weeks	1-2 weeks	-	-
	Class 3(Registration)	1-1.5 years	4-5 months	4-5 months	FDA, TGA, MHLW, EU, MHRA, Swissmedic, NMPA, MFDS
	Class 4(Registration)	1-1.5 years	4-5 months	4-5 months	FDA, TGA, MHLW, EU, MHRA, Swissmedic, NMPA, MFDS
Philippines	Class A(Notification)	1-2 months	2-4 months	-	-
	Class B(Registration)	3-6 months	4-9 months	3-5 months	FDA, EU CE Mark, ASEAN MRA
	Class C(Registration)	4-8 months	6-12 months	4-7 months	FDA, EU CE Mark, ASEAN MRA
	Class D(Full Registration)	6-12 months	9-18 months	6-10 months	FDA PMA, EU CE Mark Class III
Hong Kong	Class I(Listing)	1-2 weeks	0.5-1 months	-	-
	Class II(Listing)	1-2 months	1-3 months	0.5-1 months	FDA, EU CE Mark, Health Canada, Australia TGA, Japan PMDA
	Class III(Listing)	2-4 months	2-5 months	1-3 months	FDA, EU CE Mark, Health Canada, Australia TGA, Japan PMDA
	Class IV(Listing)	3-6 months	3-6 months	2-4 months	FDA PMA, EU CE Mark Class III
Pakistan	Class A(Notification)	1-3 months	2-4 months	-	-
	Class B(Registration)	3-6 months	4-9 months	3-5 months	FDA, EU CE Mark
	Class C(Registration)	4-8 months	6-12 months	4-7 months	FDA, EU CE Mark
	Class D(Full Registration)	6-12 months	9-18 months	6-10 months	FDA PMA, EU CE Mark Class III
Bangladesh	Class A(Notification)	1-3 months	2-5 months	-	-
	Class B(Registration)	3-6 months	4-9 months	3-6 months	FDA, EU CE Mark
	Class C(Registration)	4-8 months	6-12 months	4-8 months	FDA, EU CE Mark
	Class D(Full Registration)	6-12 months	9-18 months	6-12 months	FDA PMA, EU CE Mark Class III

Medical Device Registration Timeline

How Long Does Medical Device Registration Take?

Key Insights from Our 29-Country Analysis

Fastest Market Entry

Longest Timelines

Best ROI: MDSAP Certification

Optimal Global Strategy

Related Resources

Frequently Asked Questions